Search results
Dr Lal Pathlabs shares gain 3% after UBS projects 20% upside on improvement in patient volume growth...
CNBC TV18· 3 days agoShares of Dr Lal Pathlabs rallied 3% to hit an intraday high of ₹2,996 apiece on the BSE on Tuesday,...
UBS hikes target on Dr Lal Pathlabs, sees 20% upside on tier-III potential
CNBC Awaaz· 3 days agoUBS said Dr Lal's performance in Tier 3 markets is strong, with scope of further penetration.
Affle India shares hit 52-week high as Citi initiates with 'buy', forecasts 17% upside
CNBC Awaaz· 3 days agoIts return on equity (RoE)-focused M&A strategy should drive a business turnaround in major...
Top 5 companies that reduced the maximum debt in FY24
Livemint· 3 days agoWith the economy battling inflation and high interest rates, companies had to find a way to take...